Business, energy, technology, markets and global industry news from Business News Today

Mass General Brigham

Pharma & Biotech

eGenesis pig kidneys keep three patients dialysis-free beyond eight months as pivotal trial approaches

eGenesis says five patients have received EGEN-2784 pig kidneys under Expanded Access, with three maintaining kidney function beyond eight months and two later receiving human donor kidneys.

Read More
Medical Devices & Diagnostics

ATEV beats AV fistula in Phase 3 dialysis trial as Humacyte prepares FDA filing

Humacyte’s ATEV beats AV fistula in Phase 3 dialysis access testing as peer-reviewed V007 data strengthen its planned 2026 FDA filing.

Read More